Correlation Engine 2.0
Clear Search sequence regions


  • Ankyrin (1)
  • behaviour (4)
  • circadian rhythm (1)
  • drosophila (3)
  • Eph (7)
  • EphA1 (3)
  • ephrin (7)
  • family (2)
  • fly (2)
  • gtpase (1)
  • human (3)
  • impaired (2)
  • ligand (1)
  • living carers (1)
  • receptor (1)
  • receptor epha1 (1)
  • receptors eph (2)
  • Rho1 (2)
  • sleep (2)
  • Sizes of these terms reflect their relevance to your search.

    Alzheimer's disease (AD) is the most prevalent neurodegenerative disease placing a great burden on people living with it, carers and society. Yet, the underlying patho-mechanisms remain unknown and treatments limited. To better understand the molecular changes associated with AD, genome-wide association studies (GWAS) have identified hundreds of candidate genes linked to the disease, like the receptor tyrosine kinase EphA1. However, demonstration of whether and how these genes cause pathology is largely lacking. Here, utilising fly genetics, we generated the first Drosophila model of human wild-type and P460L mutant EphA1 and tested the effects of Eph/ephrin signalling on AD-relevant behaviour and neurophysiology. We show that EphA1 mis-expression did not cause neurodegeneration, shorten lifespan or affect memory but flies mis-expressing the wild-type or mutant receptor were hyper-aroused, had reduced sleep, a stronger circadian rhythm and increased clock neuron activity and excitability. Over-expression of endogenous fly Eph and RNAi-mediated knock-down of Eph and its ligand ephrin affected sleep architecture and neurophysiology. Eph over-expression led to stronger circadian morning anticipation while ephrin knock-down impaired memory. A dominant negative form of the GTPase Rho1, a potential intracellular effector of Eph, led to hyper-aroused flies, memory impairment, less anticipatory behaviour and neurophysiological changes. Our results demonstrate a role of Eph/ephrin signalling in a range of behaviours affected in AD. This presents a starting point for studies into the underlying mechanisms of AD including interactions with other AD-associated genes, like Rho1, Ankyrin, Tau and APP with the potential to identify new targets for treatment. Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

    Citation

    Edgar Buhl, Yoon A Kim, Tom Parsons, Bangfu Zhu, Ismael Santa-Maria, Roger Lefort, James J L Hodge. Effects of Eph/ephrin signalling and human Alzheimer's disease-associated EphA1 on Drosophila behaviour and neurophysiology. Neurobiology of disease. 2022 Aug;170:105752

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35569721

    View Full Text